摘要
目的探讨沙丁胺醇、普米克、氨溴索联合雾化吸入对婴幼儿支气管肺炎的影响。方法将100例支气管肺炎患儿随机分为观察组和对照组各50例。两组患儿均给予常规抗炎、止喘、祛痰治疗，观察组在此基础上给予沙丁胺醇、普米克、氨溴索生理盐水氧驱动雾化吸入，每日2次，7～10d。观察两组患儿治疗前后的症状消失时间、末梢静脉血氧饱和度、抗生素应用时间、平均住院日。结果两组末梢静脉血氧饱和度均有改善（P〈0．05），观察组更明显。观察组患儿的临床症状消失的时间、抗生素应用时间、平均住院日更短（P〈0．05），而且无明显不良反应发生。结论三联雾化吸入对婴幼儿支气管肺炎治疗有效．安全性高。
Objective To observe the effect of salbutamol, pulmicort and ambroxol atomized inhalation on infantile bronchopneumonia. Methods One hundred patients with infantile bronchopneumonia were randomly divided into two groups （the observation group and the control group）. The observation group was given Salbutamol, pulmieort and ambroxol by nebulizer, bid, 7 - 10 day. The duration of clinical symptoms, SpO2, the use of antibiotics, be in hospital days before and after treatment were observed. Results There were significant improvement of SpO2 in the two groups （ P 〈 0.05 ） , more obvious in the observation group. The observation group had significant shorter duration of clinical symptoms, the use of antibiotics, be in hospital days after therapy（ P 〈0.05）. No severe symtemic adverse reactions were shown in the study. Conclusions Salbutamol, pulmicort and ambroxol atomized inhalation in the treatment of patients with bronchopneumonia is effective and safe.
出处
《中国实用医刊》
2011年第19期23-24,共2页
Chinese Journal of Practical Medicine
